AD

Anil Dnyanoba Bhise

Active Director Director DIN 02794617
DIN 02794617 First appointment Nov 2009 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2009
Shareholding value •••• Premium profile

About Anil Dnyanoba Bhise

Data last updated:

Anil Dnyanoba Bhise is a Director at Dr. Silviu Pharmachem Private Limited (since 2009). The company operates in Chemicals and Materials. Dr. Silviu Pharmachem Private Limited reported revenue of ₹36.4 Lakh (FY 2021).

DIN 02794617
Primary Designation Director
Industry Chemicals and Materials
First Appointment 05 Nov 2009
Oldest Company Age 16 yrs
Largest company Dr. Silviu Pharmachem Private Limited · ₹36.4 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Nov 20092009₹36.4 Lakh (FY 2021)Active

Board colleagues of Anil Dnyanoba Bhise

NameDINCompanyDesignation
Trupti Anil Bhise02808857Dr. Silviu Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr. Silviu Pharmachem Private Limited
Premium access

Shareholding and investment profile for Anil Dnyanoba Bhise

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Dnyanoba Bhise

Anil Dnyanoba Bhise currently holds 1 directorship: Dr. Silviu Pharmachem Private Limited (Director, since 05 Nov 2009, revenue ₹36.4 Lakh (FY 2021)).

Anil Dnyanoba Bhise was first appointed on 05 Nov 2009 as Director at Dr. Silviu Pharmachem Private Limited.

The current boards of Anil Dnyanoba Bhise's companies include Trupti Anil Bhise (Dr. Silviu Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available